Abstract
Social distancing has been adopted worldwide to control severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. Social isolation is likely to lead to a decline in physical activity, which could result in immune system dysfunction, thereby increasing infection susceptibility and exacerbating the pathophysiology of conditions that are common among older adults, including cardiovascular disease, cancer, and inflammatory disorders. Older adults and people living with these comorbidities are at a greater risk for complications during coronavirus disease 2019 (COVID-19). In this review, we discuss the negative impact of physical inactivity on immune function and showcase evidence that regular physical activity may be an effective strategy to counter some of the deleterious effects of social isolation. Furthermore, we briefly highlight key research questions in exercise immunology, with a focus on older adults in the context of COVID-19. Although it is worth emphasizing that there is no direct evidence that physical activity can prevent or treat-COVID-19, promoting an active lifestyle is a key intervention to counteract the effects of social isolation, especially in older adults and other at-risk individuals, such as those living with chronic diseases associated with ageing and lifestyle.
Original language | English |
---|---|
Pages (from-to) | 431-438 |
Number of pages | 8 |
Journal | Gerontology |
Volume | 66 |
Early online date | 25 Jun 2020 |
DOIs | |
Publication status | Published - 30 Sept 2020 |
Bibliographical note
**** I will upload an authors accepted version soon ****Please see the following website: https://www.karger.com/Journal/Guidelines/224091#sec63
Archiving and Self-Archiving
All articles are archived in PubMed Central and/or Portico. Karger permits authors to archive their postprints (i.e., accepted manuscripts after peer review but before production) on their personal home page or institution’s repository, provided that these are not used for commercial purposes, are linked to the publisher’s version, and acknowledge the publisher’s copyright. Preprints may be shared without restriction.
In addition, authors may post their accepted manuscripts in public Open Access repositories and scientific networks no earlier than 12 months following publication of the final version of their article. The posted manuscripts must:
1. Be used for noncommercial purposes only
2. Be linked to the final version on www.karger.com and include the following statement:
"This is the peer-reviewed but unedited manuscript version of the following article: [insert full citation, e.g., Cytogenet Genome Res 2014;142:227–238 (DOI: 10.1159/000361001)]. The final, published version is available at http://www.karger.com/?doi=[insert DOI number]."
It is the authors’ responsibility to fulfill these requirements.
For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.
Manuscripts to be archived in PubMed Central due to funding requirements or that have been published under the Author’s Choice™ scheme will be submitted by Karger on the authors’ behalf, as outlined under Funding Organizations.
Keywords
- Coronavirus
- Health
- Immunology
- Inflammation
- Older adults
ASJC Scopus subject areas
- Ageing
- Geriatrics and Gerontology